Information contributed by meta-analysis in exposure–response modeling: application to phase 2 dose selection of guselkumab in patients with moderate-to-severe psoriasis
Crossref DOI link: https://doi.org/10.1007/s10928-014-9360-6
Published Online: 2014-05-23
Published Print: 2014-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hu, Chuanpu
Wasfi, Yasmine
Zhuang, Yanli
Zhou, Honghui
Text and Data Mining valid from 2014-05-23